UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by MJP Associates Inc. ADV

MJP Associates Inc. ADV boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,190 shares of the healthcare conglomerate’s stock after purchasing an additional 112 shares during the quarter. MJP Associates Inc. ADV’s holdings in UnitedHealth Group were worth $1,246,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in UNH. Atom Investors LP acquired a new stake in UnitedHealth Group in the 2nd quarter valued at about $1,723,000. GWM Advisors LLC boosted its stake in shares of UnitedHealth Group by 8.3% during the 2nd quarter. GWM Advisors LLC now owns 31,240 shares of the healthcare conglomerate’s stock worth $12,510,000 after purchasing an additional 2,397 shares during the last quarter. Seven Springs Wealth Group LLC boosted its stake in shares of UnitedHealth Group by 58.6% during the 2nd quarter. Seven Springs Wealth Group LLC now owns 2,544 shares of the healthcare conglomerate’s stock worth $1,019,000 after purchasing an additional 940 shares during the last quarter. Parametric Portfolio Associates LLC boosted its stake in shares of UnitedHealth Group by 2.2% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,874,820 shares of the healthcare conglomerate’s stock worth $1,551,633,000 after purchasing an additional 81,995 shares during the last quarter. Finally, Welch & Forbes LLC boosted its stake in shares of UnitedHealth Group by 46.2% during the 2nd quarter. Welch & Forbes LLC now owns 4,572 shares of the healthcare conglomerate’s stock worth $1,831,000 after purchasing an additional 1,445 shares during the last quarter. Hedge funds and other institutional investors own 86.20% of the company’s stock.

Shares of UNH stock traded up $5.46 during mid-day trading on Tuesday, reaching $443.00. 32,692 shares of the company were exchanged, compared to its average volume of 2,943,648. UnitedHealth Group Incorporated has a fifty-two week low of $320.35 and a fifty-two week high of $466.00. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.77 and a current ratio of 0.77. The company has a market capitalization of $417.24 billion, a P/E ratio of 27.14, a P/E/G ratio of 1.75 and a beta of 0.85. The business’s 50 day simple moving average is $429.12 and its 200 day simple moving average is $417.57.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share for the quarter, topping analysts’ consensus estimates of $4.41 by $0.11. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The business had revenue of $72.34 billion during the quarter, compared to the consensus estimate of $71.24 billion. During the same quarter last year, the company earned $3.51 earnings per share. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. On average, analysts forecast that UnitedHealth Group Incorporated will post 18.84 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 14th. Stockholders of record on Monday, December 6th will be issued a dividend of $1.45 per share. This represents a $5.80 annualized dividend and a dividend yield of 1.31%. The ex-dividend date of this dividend is Friday, December 3rd. UnitedHealth Group’s dividend payout ratio (DPR) is 35.98%.

In related news, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction dated Tuesday, September 14th. The shares were sold at an average price of $416.75, for a total transaction of $1,041,875.00. Following the sale, the director now directly owns 154,403 shares in the company, valued at $64,347,450.25. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Stephen J. Hemsley sold 75,000 shares of the business’s stock in a transaction dated Monday, October 25th. The stock was sold at an average price of $448.72, for a total transaction of $33,654,000.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 80,000 shares of company stock valued at $35,743,375. Corporate insiders own 0.55% of the company’s stock.

Several equities research analysts recently issued reports on UNH shares. Evercore ISI raised their target price on shares of UnitedHealth Group from $360.00 to $480.00 and gave the stock an “outperform” rating in a research report on Friday, October 15th. SVB Leerink started coverage on shares of UnitedHealth Group in a research report on Monday, September 27th. They issued an “outperform” rating and a $480.00 target price on the stock. Cowen started coverage on shares of UnitedHealth Group in a research report on Thursday, September 9th. They issued an “outperform” rating and a $478.00 target price on the stock. Oppenheimer raised their target price on shares of UnitedHealth Group from $465.00 to $475.00 and gave the stock an “outperform” rating in a research report on Friday, October 15th. Finally, Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $478.00 to $520.00 and gave the stock an “overweight” rating in a research report on Monday, October 25th. One equities research analyst has rated the stock with a hold rating, twenty-one have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $477.35.

UnitedHealth Group Company Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Recommended Story: Hedge Funds Explained

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.